US Bancorp’s DermTech, Inc. Common Stock DMTK Stock Holding History

US Bancorp’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-400	Closed	-$576	–	4181
2023 Q3	$576	Hold	400	–	–	﹤0.01%	3829
2023 Q2	$1.04K	Hold	400	–	–	﹤0.01%	3801
2023 Q1	$1.47K	Hold	400	–	–	﹤0.01%	3823
2022 Q4	$708	Hold	400	–	–	﹤0.01%	3963
2022 Q3	$2K	Hold	400	–	–	﹤0.01%	3883
2022 Q2	$2K	Sell	400 -365	-48%	-$2.99K	﹤0.01%	3900
2022 Q1	$12K	Sell	765 -219	-22%	-$2.93K	﹤0.01%	3325
2021 Q4	$16K	Sell	984 -25	-2%	-$600	﹤0.01%	3245
2021 Q3	$32K	Buy	1,009 +621	+160%	+$21.8K	﹤0.01%	2886
2021 Q2	$16K	Buy	388 +23	+6%	+$945	﹤0.01%	3254
2021 Q1	$19K	Buy	365 +265	+265%	+$13.9K	﹤0.01%	3060
2020 Q4	$3K	Buy	+100	New	+$1.42K	﹤0.01%	3532

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

US Bancorp's DMTK Position: Q4 2023 in Review

US Bancorp sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 400 shares — an estimated $576 sold.

US Bancorp first reported a position in DMTK in Q4 2020 and held it in 12 quarters. The position peaked at $32K in Q3 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

US Bancorp reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 400 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $576.
US Bancorp first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
US Bancorp's DermTech, Inc. Common Stock position peaked at $32K in Q3 2021.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.